Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: A meta-analysis - 29/06/13
Riassunto |
Background |
Optimization of atrioventricular (AV) and ventriculoventricular (VV) delays of cardiac resynchronization therapy (CRT) devices maximizes left ventricular filling and stroke volume. However, the incremental value of these optimizations over empiric device programming remains unclear. The objective of this analysis was to perform a systematic review and meta-analysis of the effects of AV and VV delay optimization on clinical and echocardiographic end points of patients with heart failure treated with CRT.
Methods |
A standardized search strategy was performed and identified 12 trials comparing AV and/or VV delay optimization and conventional CRT device programming and their effects on various clinical and echocardiographic outcomes. Pooled odds ratios were analyzed using random-effect meta-analysis with Mantel-Haenszel method.
Results |
Combined data from a total of 4,356 patients with heart failure treated with CRT showed no differences in clinical or echocardiographic outcomes between patients who underwent AV and/or VV delay optimization and patients who underwent empiric device programming (Mantel-Haenszel odds ratio 0.86 [95% CI 0.68-1.09], P value for overall effect = .21 by intention-to-treat analysis).
Conclusion |
The current literature suggests that routine AV and/or VV delay optimization has a neutral effect on clinical and echocardiographic outcomes based on pooled data from randomized and nonrandomized studies. Standardization of patient selection and optimization timing and method may help to further define the role of CRT device optimization.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 166 - N° 1
P. 20-29 - Luglio 2013 Ritorno al numero
Articolo precedente
- Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): A randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation
- Massimo Imazio, Riccardo Belli, Antonio Brucato, Paolo Ferrazzi, Davide Patrini, Luigi Martinelli, Vincenzo Polizzi, Roberto Cemin, Anna Leggieri, Alida L.P. Caforio, Yaron Finkelstein, Brian Hoit, Bernhard Maisch, Bongani M. Mayosi, Jae K. Oh, Arsen D. Ristic, Petar Seferovic, David H. Spodick, Yehuda Adler
- Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men
- Cathrin Balmelli, Christophe Meune, Raphael Twerenbold, Tobias Reichlin, Simone Rieder, Beatrice Drexler, Maria Gimenez Rubini, Tamina Mosimann, Miriam Reiter, Philip Haaf, Mira Mueller, Susanne Ernst, Paola Ballarino, Azza A. Alafify, Christa Zellweger, Karin Wildi, Berit Moehring, Carles Vilaplana, Denise Bernhard, Salome Merk, Stefan Ebmeyer, Heike Freidank, Stefan Osswald, Christian Mueller
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?